Marc Campayo

oncology department

H指数:10

被引数:556

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Socio-demographic factors, tumor characteristics, treatments administered, and survival in cancer patients in a prison hospitalization unit: a retrospective cohort comparison with matched community controls

社会人口因素、肿瘤特征、接受的治疗以及监狱住院单元中癌症患者的生存情况：一项与匹配社区对照组的回顾性队列比较研究

BMC Cancer

IF3.4

2025-12-190

OAAI

Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study

西班牙早期可切除非小细胞肺癌患者中EGFR基因突变的发生率：ORIGEN研究

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2025-04-010

Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer

CLINICAL LUNG CANCER

IF3.3

2024-05-014

PRE

Riudavets, Mariona; Auclin, Edouard; Mosteiro, Miguel; Dempsey, Naomi; Majem, Margarita; Prelaj, Arsela; Lopez-Castro, Rafael; Bosch-Barrera, Joaquim; Pilotto, Sara; Escalera, Elena; Tagliamento, Marco; Mosquera, Joaquin; Zalcman, Gerard; Nana, Frank Aboubakar; Ponce, Santiago; Albarran-Artahona, Victor; Dal Maso, Alessandro; Spotti, Martina; Mielgo, Xabier; Mussat, Elodie; Reyes, Roxana; Benitez, Jose -Carlos; Lupinacci, Lorena; Duchemann, Boris; De Giglio, Andrea; Blaquier, Juan Bautista; Audigier-Valette, Clarisse; Scheffler, Matthias; Nadal, Ernest; Lopes, Gilberto; Signorelli, Diego; Garcia-Campelo, Rosario; Menis, Jessica; Bluthgen, Virginia; Campayo, Marc; Recondo, Gonzalo; Besse, Benjamin; Mezquita, Laura; Planchard, David

Original Research Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

原始研究Durvalumab巩固治疗具有驱动基因组改变的不可切除的III期非小细胞肺癌患者

EUROPEAN JOURNAL OF CANCER

IF7.1

2022-05-0132

OAAI

Riudavets, Mariona; Auclin, Edouard; Mosteiro, Miguel; Dempsey, Naomi; Majem, Margarita; Lobefaro, Riccardo; Lopez-Castro, Rafael; Bosch-Barrera, Joaquim; Pilotto, Sara; Escalera, Elena; Tagliamento, Marco; Mosquera, Joaquin; Zalcman, Gerard; Aboubakar-Nana, Frank; Ponce, Santiago; Dal Maso, Alessandro; Spotti, Martina; Mielgo-Rubio, Xabier; Mussat, Elodie; Reyes, Roxana; Benitez, Jose-Carlos; Lupinacci, Lorena; Duchemann, Boris; De Giglio, Andrea; Blaquier, Juan; Audigier-Valette, Clarisse; Scheffler, Matthias; Nadal, Ernest; Lopes, Gilberto; Signorelli, Diego; Garcia-Campelo, Rosario; Menis, Jessica; Bluthgen, Virginia; Campayo, Marc; Recondo, Gonzalo; Besse, Benjamin; Planchard, David; Mezquita, Laura

Association between the lung immune prognostic index (LIPI) and durvalumab consolidation outcomes in patients with locally advanced non-small cell lung cancer (NSCLC)

ANNALS OF ONCOLOGY

IF65.4

2021-12-010